Diabetes mellitus and breast cancer outcomes: A systematic review and meta-analysis

Journal of Clinical Oncology

Volumn 29, Issue 1, 2011, Pages 40-46

  Peairs, Kimberly S ^a   Barone, Bethany B ^a   Snyder, Claire F ^a   Yeh, Hsin Chieh ^a   Stein, Kelly B ^a   Derr, Rachel L ^a   Brancati, Frederick L ^a   Wolff, Antonio C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; INSULIN; TAXANE DERIVATIVE;

ADVANCED CANCER; ANEMIA; ARTICLE; AXILLARY LYMPH NODE EXTIRPATION; BREAST CANCER; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEBRILE NEUTROPENIA; GLYCEMIC INDEX; HAZARD RATIO; HUMAN; INFECTION; LYMPH NODE DISSECTION; META ANALYSIS; NEUTROPENIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

BREAST NEOPLASMS; DIABETES MELLITUS; FEMALE; HUMANS; INSULIN RESISTANCE; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS;

EID: 79951960884     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.27.3011     Document Type: Article

References (32)

1. Anderson GF, Chu E: Expanding priorities: Confronting chronic disease in countries with low income. N Engl J Med 356:209-211, 2007 (Pubitemid 46143222)
2. National Institute of Diabetes and Digestive and Kidney Diseases: National Diabetes Statistics Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2007. Bethesda, MD, US Dept of Health and Human Services, National Institutes of Health, 2007
3. American Cancer Society: Breast Cancer Facts and Figures 2007-2008. Atlanta, GA, American Cancer Society, 2008
4. Chapman JA, Meng D, Shepherd L, et al: Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer. J Natl Cancer Inst 100:252-260, 2008 (Pubitemid 351480540)
5. Beckman TJ, Cuddihy RM, Scheitel SM, et al: Screening mammogram utilization in women with diabetes. Diabetes Care 24:2049-2053,2001 (Pubitemid 33716519)
6. Lipscombe LL, Goodwin PJ, Zinman B, et al: The impact of diabetes on survival following breast cancer. Breast Cancer Res Treat 109:389-395, 2008 (Pubitemid 351644852)
7. Alimova IN, Liu B, Fan Z, et al: Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle 8:909-915, 2009
8. Vazquez-Martin A, Oliveras-Ferraros C, Del Barco S, et al: If mammalian target of metformin indirectly is mammalian target of rapamycin, then the insulin-like growth factor-1 receptor axis will audit the efficacy of metformin in cancer clinical trials. J Clin Oncol 27:e207-e209; author reply e210, 2009
9. Jiralerspong S, Palla SL, Giordano SH, et al: Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol 27:3297-3302, 2009
10. Cazzaniga M, Bonanni B, Guerrieri-Gonzaga A, et al: Is it time to test metformin in breast cancer clinical trials? Cancer Epidemiol Biomarkers Prev 18:701-705, 2009
11. Goodwin PJ, Ligibel JA, Stambolic V: Metformin in breast cancer: Time for action. J Clin Oncol 27; 3271-3273, 2009
12. Barone BB, Yeh H-C, Snyder CF, et al: Long-term, all-cause mortality in cancer patients with preexisting diabetes mellitus: A systematic review and meta-analyisis. JAMA 300:2754-2764, 2008
13. von Elm E, Altman DG, Egger M, et al: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Epidemiology 18:800-804, 2007 (Pubitemid 350295184)
14. Higgins JP, Thompson SG, Deeks JJ, et al: Measuring inconsistency in meta-analyses. BMJ 327:557-560, 2003 (Pubitemid 37088507)
15. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 7:177-188, 1986 (Pubitemid 17189972)
16. Duval S, Tweedie R: Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455-463, 2000 (Pubitemid 30422636)
17. Yancik R, Wesley MN, Ries LA, et al: Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285:885-892, 2001 (Pubitemid 32171549)
18. van de Poll-Franse LV, Houterman S, Janssen- Heijnen ML, et al: Less aggressive treatment and worse overall survival in cancer patients with diabetes: A large population based analysis. Int J Cancer 120:1986-1992, 2007
19. Srokowski TP, Fang S, Hortobagyi GN, et al: Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J Clin Oncol 27:2170-2176, 2009
20. Tammemagi CM, Nerenz D, Neslund-Dudas C, et al: Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 294; 1765-1772, 2005 (Pubitemid 41434622)
21. Du W, Simon MS: Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit. Breast Cancer Res Treat 91:243-248, 2005 (Pubitemid 40896570)
22. Fleming ST, Pursley HG, Newman B, et al: Comorbidity as a predictor of stage of illness for patients with breast cancer. Med Care 43:132-140, 2005 (Pubitemid 40222631)
23. Fleming ST, Rastogi A, Dmitrienko A, et al: A comprehensive prognostic index to predict survival based on multiple comorbidities: A focus on breast cancer. Med Care 37:601-614, 1999
24. Gregg EW, Gu Q, Cheng YJ, et al: Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med 147:149-155, 2007
25. Maruthur NM, Bolen S, Brancati FL, et al: Obesity and mammography: A systematic review and meta-analysis. J Gen Intern Med 24:665-677, 2009
26. Wolf I, Sadetzki S, Catane R, et al: Diabetes mellitus and breast cancer. Lancet Oncol 6:103-111, 2005 (Pubitemid 40197704)
27. Calle EE, Kaaks R: Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579-591, 2004 (Pubitemid 39025053)
28. Renehan AG, Frystyk J, Flyvbjerg A: Obesity and cancer risk: The role of the insulin-IGF axis. Trends Endocrinol Metab 17:328-336, 2006 (Pubitemid 44397568)
29. Pollak MN, Schernhammer ES, Hankinson SE: Insulin-like growth factors and neoplasia. Nat Rev Cancer 4:505-518, 2004 (Pubitemid 38868620)
30. Goodwin PJ, Pritchard KI, Ennis M, et al: Insulin-lowering effects of metformin in women with early breast cancer. Clin Breast Cancer 8:501-505, 2008
31. Monami M, Lamanna C, Balzi D, et al: Sulphonylureas and cancer: A case-control study. Acta Diabetol 46:279-284, 2009
32. Bowker SL, Yasui Y, Veugelers P, et al: Glucose-lowering agents and cancer mortality rates in type 2 diabetes: Assessing effects of time-varying exposure. Diabetologia 53:1631-1637, 2010